Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STORC: Sofosbuvir/Velpatasvir in Treatment of Chronic Hepatitis C Virus During Pregnancy
NCT05140941Phase 4Active, not recruiting
- Start
- Apr 2022
- Primary completion
- Sep 2026
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 4 trial of sofosbuvir + velpatasvir in hepatitis C virus infection. Started Apr 2022; status: active, not recruiting.
02
Drugs
sofosbuvir + velpatasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT05140941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05140941.